feed,title,long_url,short_url
SeekingAlpha,Inhibrx announces initial results from phase 1 trial of INBRX-106 in treating solid tumors,https://seekingalpha.com/news/3785225,
SeekingAlpha,"MillerKnoll EPS misses by $0.05, misses on revenue",https://seekingalpha.com/news/3785224,
